Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Bates

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Pathology|May 14, 2004
Co-expression of neuregulins 1, 2, 3 and 4 in human breast cancerMariana Dunn, Prakash Sinha, Rebecca Campbell, et al.
Research Square|June 30, 2025
AI-Enabled Diagnostic Prediction within Electronic Health Records to Enhance Biosurveillance and Early Outbreak DetectionAndre Goncalves, Jose Cadena, Yeping Hu, et al.
BMJ Open|April 19, 2018
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancerJohn Conibear, Brendan Chia, Yenting Ngai, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Pathology|May 14, 2004
Co-expression of neuregulins 1, 2, 3 and 4 in human breast cancerMariana Dunn, Prakash Sinha, Rebecca Campbell, et al.
Research Square|June 30, 2025
AI-Enabled Diagnostic Prediction within Electronic Health Records to Enhance Biosurveillance and Early Outbreak DetectionAndre Goncalves, Jose Cadena, Yeping Hu, et al.
BMJ Open|April 19, 2018
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancerJohn Conibear, Brendan Chia, Yenting Ngai, et al.
Pageof 2